1. Home
  2. ACCL vs NSRX Comparison

ACCL vs NSRX Comparison

Compare ACCL & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Group Holdings Limited Ordinary Shares

ACCL

Acco Group Holdings Limited Ordinary Shares

SELL

Current Price

$2.40

Market Cap

36.3M

ML Signal

SELL

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$2.72

Market Cap

37.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACCL
NSRX
Founded
2009
2019
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
37.1M
IPO Year
2024
2024

Fundamental Metrics

Financial Performance
Metric
ACCL
NSRX
Price
$2.40
$2.72
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $16.50
AVG Volume (30 Days)
1.7K
★ 14.0K
Earning Date
11-27-2026
08-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.13
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.23
$1.98
52 Week High
$4.98
$9.50

Technical Indicators

Market Signals
Indicator
ACCL
NSRX
Relative Strength Index (RSI) 39.61 29.72
Support Level $1.33 $2.41
Resistance Level $2.89 $3.61
Average True Range (ATR) 0.06 0.23
MACD -0.02 -0.03
Stochastic Oscillator 21.98 4.49

Price Performance

Historical Comparison
ACCL
NSRX

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: